Meritage Portfolio Management Bio Rad Laboratories, Inc. Transaction History

Meritage Portfolio Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$524.57 - $735.42 $15.4 Million - $21.6 Million	-29,397 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$708.84 - $794.68 $292,042 - $327,408	-412 Reduced 1.38%	29,397 $22.2 Million
Q3 2021 Oct 26, 2021	BUY	$657.71 - $825.77 $22,362 - $28,076	34 Added 0.11%	29,809 $22.2 Million
Q2 2021 Jul 26, 2021	SELL	$576.64 - $649.04 $179,335 - $201,851	-311 Reduced 1.03%	29,775 $19.2 Million
Q1 2021 Apr 27, 2021	SELL	$547.01 - $662.35 $673,369 - $815,352	-1,231 Reduced 3.93%	30,086 $17.2 Million
Q4 2020 Feb 03, 2021	BUY	$510.68 - $643.45 $67,920 - $85,578	133 Added 0.43%	31,317 $18.3 Million
Q3 2020 Oct 26, 2020	SELL	$454.43 - $535.6 $47,260 - $55,702	-104 Reduced 0.33%	31,184 $16.1 Million
Q2 2020 Jul 27, 2020	BUY	$334.87 - $493.06 $403,183 - $593,644	1,204 Added 4.0%	31,288 $14.1 Million
Q1 2020 Apr 27, 2020	BUY	$320.01 - $409.07 $9.63 Million - $12.3 Million	30,084 New	30,084 $10.5 Million

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.15B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

Stay updated on Meritage Portfolio Management with notifications on news.